Carcino3D™ Bioprinting Technology

Harness the Power of 3D-bioprinted Tumors

We apply engineering principles to develop uniform tumor models that replicate the architecture of human tumors.

Engineering the Next Generation of Cancer Models

Emerging therapeutic modalities are exceeding the capabilities of traditional 3D in vitro models.

Carcinotech addresses this challenge with its Carcino3D™ technology, creating human tumors in an assay-ready format. These models provide organizations with a faster, more reproducible, and highly relevant platform for cancer drug testing.

99%

Genetic similarity to the patient tumor material

20+

Primary cell types included within our printed tumor models

Up to 400

Tumor models produced from a single tumor biopsy

3

Months our tumor models can be cryopreserved

Benefits of 3D-bioprinted Tumors

Carcino3D™ technology bioprints tumors derived from patient biopsies, offering multiple benefits compared to traditional in vitro and in vivo models.

Structural Relevance and Controlled Development

3D bioprinting offers precise control over spatial patterning and mechanical properties, accurately replicating in vivo tumor architecture for each cancer type. This precision prevents necrotic core formation, enabling more physiologically relevant models.

Uniformity and Reproducibility

Our fully automated printing capabilities ensure uniformity across every bioprinted tumor, enhancing reproducibility and offering experimental control, which are essential for clinical translation.

Ready-to-test Format

Our 3D-bioprinted tumors are manufactured assay-ready in 96 or 384-well plates and require no downstream processing, allowing for seamless integration into your existing workflows.

Easily Perfused

3D bioprinting allows precise control over porosity, closely mimicking the natural organization of tissues. This architectural fidelity enables realistic perfusion of the bioprinted constructs, which is essential for effective drug screening.

Application Note

Carcino3D™ Lung Model

Explore the effectiveness of our 3D-bioprinted lung cancer model for screening chemotherapies.

View Application Note

3D-bioprinted Models for Multiple Applications

Whether you need 3D cancer models for drug drug discovery or efficacy studies, we have the flexibility to bioprint models for a variety of use cases and indications.

Early Drug Discovery

Preclinical Testing

Frequently Asked Questions

What is 3D-bioprinting?

3D-bioprinting is an automated fabrication method that offers unparalleled accuracy, resolution, and precision compared to self-forming techniques used in traditional 3D in vitro models.

Do your models require a scaffold?

No. Our cancer-specific extracellular matrix (ECM) component mix incorporates natural ECM components that not only provide structural support for our bioprinted tumor models but also offer a more accurate representation of the tumor microenvironment.

How do your 3D-bioprinted models differ from tumor organoids derived from dissociated tissue?

Our models deliver on the unmet potential of tumor organoids. Explore our comparison table for detailed insights.

Can your 3D-bioprinted models be customized?

Yes, we can 3D-bioprint models for a wide range of solid tumor types. Additionally, our models are modality-agnostic, allowing for flexibility in therapeutic applications.

Ready to Transition to 3D-bioprinted Tumors?

Contact us to learn more about customized 3D-bioprinted tumors tailored specifically for your research or healthcare facility.

Contact us